Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 17, 2024 07:52 ET | Source: ZyVersa Therapeutics

ZyVersa Therapeutics Highlights Peer-Reviewed Article Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis

NLRP3 Inflammasome Activation Is Linked to Brain Metastasis in Patients with Triple-Negative Breast Cancer.
December 26, 2022 04:00 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Gamma Knife Market Holds a Worth of US$ 343.1 Mn as of 2023, and by 2033, it is Estimated to Reach a Revenue of US$ 600 Mn at CAGR of 5.7% During Forecast Period of 2023-33 | Future Market Insights, Inc.

NEWARK, Del, Dec. 26, 2022 (GLOBE NEWSWIRE) -- The global gamma knife market is valued at US$ 343.1 million as of 2023. The market is expected to grow at a CAGR of 5.7% during the forecast period,...
June 03, 2021 11:45 ET | Source: Acumen Research and Consulting

Brain Metastasis Therapeutic Market In North America Is Expected To Account For Major Revenue Share Covering COVID-19 Impact: Acumen Research And Consulting

LOS ANGELES, June 03, 2021 (GLOBE NEWSWIRE) -- Brain metastasis occur when cancer cells spread from their original site to the brain. As the metastatic brain tumors grow, they create pressure on and...
June 03, 2021 08:30 ET | Source: CMI

Global Gamma Knife Market to surpass US$ 294.5 million by 2027, Says Coherent Market Insights (CMI)

SEATTLE, June 03, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global gamma knife market is estimated to be valued at US$ 215.8 million in 2020 and is expected to exhibit a...